Miller-The ASAM Principles of Addiction Medicine, 7e

xxxi

Contents

58 Management of Opioid Intoxication and Withdrawal 908 Kenneth L. Morford, Julia M. Shi, Patrick G. O’Connor, and Jeanette M. Tetrault 59 Management of Stimulant, Hallucinogen, Cannabis, Phencyclidine, and Other Drug Intoxication and Withdrawal 923 Jeffery N. Wilkins, David A. Gorelick, Itai Danovitch, Nicholas Athanasiou, and Steven Allen SECTION 8 PHARMACOLOGICAL INTERVENTIONS AND OTHER SOMATIC THERAPIES 945 60 Pharmacological Interventions for Alcohol Use Disorder 946 Norah Essali, Hugh Myrick, and Andrew J. Saxon 61 Pharmacological Interventions for Sedative-Hypnotic Use Disorder 961 Alyssa Braxton, Jeffrey S. Cluver, Tara M. Wright, and Hugh Myrick 62 Pharmacological Treatment for Opioid Use Disorder 969 David Kan and Joan E. Zweben Sidebar Medical Director Stewardship of Opioid Treatment Programs 994 Kenneth B. Stoller 63 Special Issues in Office-Based Opioid Treatment (OBOT) 999 Amy J. Kennedy and Andrew J. Saxon 64 Pharmacological Treatment of Stimulant Use Disorders 1014 David A. Gorelick and Jeffery N. Wilkins 65 Pharmacological Interventions for Nicotine and Tobacco Use 1030 Randi M. Williams, Frank T. Leone, and Robert Schnoll 66 Pharmacological Interventions for Other Substances and Multiple Substance Use Disorders 1045 Jeffery N. Wilkins, Mark Hrymoc, Manjit Bhandal, and David A. Gorelick 67 Complementary and Integrative Interventions for Substance Use Disorders 1052 Ripal Shah and David Spiegel 68 Neuromodulation for Substance Use Disorders 1064 Colleen A. Hanlon, Kaitlin R. Kinney, Miranda P. Ramirez, and Michael J. Wesley

74 Behavioral Interventions for Tobacco Use Disorder 1143 Joanna M. Streck, Angela Wangari Walter, Rachel L. Rosen, and Elyse R. Park 75 Network Therapy 1164 Marc Galanter 76 Therapeutic Communities and Modified Therapeutic Communities for Co-occurring Mental and Substance Use Disorders 1175 George De Leon and Stanley Sacks 77 Aversion Therapies 1189 Hanne Tonnesen, P. Joseph Frawley, and Richard Montgomery 78 Family Involvement in Addiction, Treatment, and Recovery 1198 Julianne C. Flanagan and Brandi C. Fink 79 Twelve-Step Facilitation Approaches 1213 Antoine Douaihy, Dennis M. Donovan, and Dennis C. Daley 80 Relapse Prevention: Clinical Models and Intervention Strategies 1219 Antoine Douaihy, Dennis C. Daley, and Dennis M. Donovan 81 Mindfulness-Based Treatment of Addiction 1236 Eric L. Garland and Anna Parisi 82 Digital Health Interventions for Substance Use Disorders: The State of the Science 1250 Smita Das 83 Medical Management Techniques and Collaborative Care: Integrating Behavioral With Pharmacological Interventions 1261 Richard N. Rosenthal, Richard K. Ries, and Joan E. Zweben SECTION 10 MUTUAL HELP: TWELVE STEP AND OTHER PROGRAMS IN ADDICTION RECOVERY 1278 84 Twelve-Step and Other Programs in Addiction Recovery 1279 Edgar P. Nace 85 Recent Research Into Twelve-Step Programs 1289 John F. Kelly 86 Spirituality in the Recovery Process 1308 Marc Galanter

SECTION 9 PSYCHOLOGICALLY BASED INTERVENTIONS 1073 69 Enhancing Motivation to Change 1074 James O. Prochaska and Janice M. Prochaska 70 Motivational Interviewing 1085 SECTION 11 MEDICAL DISORDERS AND COMPLICATIONS OF ADDICTION 1313 87 Medical Care of Patients With Unhealthy Substance Use 1314 Darius A. Rastegar 88 Cardiovascular Disorders Related to Substance Use 1335 Andi Shahu, Steven E. Pfau, and Samit M. Shah 89 Liver Disorders Related to Substance Use 1355 Paul S. Haber and Emily Nash 90 Renal and Metabolic Disorders Related to Substance Use 1376 Sarah Gilligan and Naveen Rathi Copyright © 2024 Wolters Kluwer, Inc. Unauthorized reproduction of the content is prohibited. Cassandra L. Boness, Antoine Douaihy, and Karen S. Ingersoll 71 Group Therapies 1094 Dennis C. Daley, Antoine Douaihy, and Roger D. Weiss 72 Individual Treatment 1107 Edward V. Nunes and Kenneth M. Carpenter 73 Contingency Management and the Community Reinforcement Approach 1128 Sarah H. Heil, Tyler G. Erath, Roxanne F. Harfmann, and Stephen T. Higgins